KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Twist Bioscience (TWST) Accumulated Depreciation & Amortization (2018 - 2025)

Twist Bioscience (TWST) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $20.8 million as the latest value for Q2 2023.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 79.99% to $20.8 million in Q2 2023 year-over-year; TTM through Jun 2023 was $20.8 million, a 79.99% increase, with the full-year FY2022 number at $16.5 million, up 68.51% from a year prior.
  • Accumulated Depreciation & Amortization was $20.8 million for Q2 2023 at Twist Bioscience, up from $12.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $20.8 million in Q2 2023 to a low of $3.2 million in Q4 2021.
  • A 5-year average of $9.9 million and a median of $8.5 million in 2021 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: rose 6.71% in 2019, then skyrocketed 79.99% in 2023.
  • Twist Bioscience's Accumulated Depreciation & Amortization stood at $6.1 million in 2019, then increased by 9.64% to $6.7 million in 2020, then plummeted by 52.99% to $3.2 million in 2021, then soared by 68.0% to $5.3 million in 2022, then surged by 293.24% to $20.8 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Accumulated Depreciation & Amortization are $20.8 million (Q2 2023), $12.3 million (Q1 2023), and $5.3 million (Q4 2022).